The Chinese Society of Clinical Oncology (CSCO) and Society for Translational Oncology (STO) collectively value the importance of innovative and professional career development for young Chinese oncologists. Through strategic relationships with world-class institutions, sharing clinical programs, and collaborative research projects, the International Fellowship Program (IFP) is designed to address China’s pressing need for more oncologists with advanced clinical skills.
The IFP targets China’s rising stars as they prepare for careers as the next generation of independent clinical investigators and scientific experts in academia, the pharmaceutical industry or government. During this era of rapid development of precision medicine/personalized cancer therapies, immunotherapy, and novel drug development, this program concentrates on building professional skills in clinical trials, precision medicine, and immuno-oncology. Applicants were nominated by the CSCO leadership and then selected by the IFP Joint Fellowship Committee following a series of interviews.
During the three-month program, fellows worked closely with faculties from Alliance for Clinical Trials in Oncology, Harvard Medical School, Dana-Farber Cancer Institute, STO Chabner Colloquium, STO Fellows' Forum, Mayo Clinic Cancer Center, and US Food and Drug Administration (FDA) to expand their knowledge and enhance their professional skills in clinical trials, precision medicine, and immuno-oncology.
Copyright © 2022. All rights reserved.